Haga, Hironori

Publications

Impact Factor

Cites

Reference	Impact Factor	Cites	Quartile
Koshiba T, Li Y, Takemura M, Wu Y, Sakaguchi S, Minato N, Wood KJ, Haga H, Ueda M, Uemoto S. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol. 2007 Feb;17(2):94-7. Epub 2006 Nov 10. PubMed PMID: 17306739.	1.624	145	3
Li Y, Zhao X, Cheng D, Haga H, Tsuruyama T, Wood K, Sakaguchi S, Tanaka K, Uemoto S, Koshiba T. The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients. Transplantation. 2008 Dec 27;86(12):1837-43. doi: 10.1097/TP.0b013e31818febc4. PubMed PMID: 19104431.	4.546	96	1
Yoshitomi M, Koshiba T, Haga H, Li Y, Zhao X, Cheng D, Miyagawa A, Sakashita H, Tsuruyama T, Ohe H, Ueda M, Okamoto S, Egawa H, Wood K, Sakaguchi S, Manabe T, Tanaka K, Uemoto S. Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation. Transplantation. 2009 Feb 27;87(4):606-14. doi: 10.1097/TP.0b013e318195a7cb. Erratum in: Transplantation. 2009 Apr 15;87(7):1104. PubMed PMID: 19307800.	4.546	89	1
Egawa H, Miyagawa-Hayashino A, Haga H, Teramukai S, Yoshizawa A, Ogawa K, Ogura Y, Okamoto S, Kaido T, Uemoto S. Non-inflammatory centrilobular sinusoidal fibrosis in pediatric liver transplant recipients under tacrolimus withdrawal. Hepatol Res. 2012 Sep;42(9):895-903. doi: 10.1111/j.1872-034X.2012.01003.x. Epub 2012 Apr 23. PubMed PMID: 22524409.	3.165	34	3
Aini W, Miyagawa-Hayashino A, Ozeki M, Adeeb S, Hirata M, Tamaki K, Uemoto S, Haga H. Accelerated telomere reduction and hepatocyte senescence in tolerated human liver allografts. Transpl Immunol. 2014 Aug;31(2):55-9. doi: 10.1016/j.trim.2014.06.008. Epub 2014 Jun 30. PubMed PMID: 24993398.	1.624	15	3
Aini W, Miyagawa-Hayashino A, Ozeki M, Tsuruyama T, Tamaki K, Uemoto S, Haga H. Frequent hepatocyte chimerism in long-term human liver allografts independent of graft outcome. Transpl Immunol. 2013 Mar;28(2-3):100-5. doi: 10.1016/j.trim.2012.12.002. Epub 2012 Dec 22. PubMed PMID: 23268137.	1.624	7	3
Hai Nam N, Taura K, Koyama Y, Nishio T, Yamamoto G, Uemoto Y, Kimura Y, Xuefeng L, Nakamura D, Yoshino K, Ogawa E, Okamoto T, Yoshizawa A, Seo S, Iwaisako K, Yoh T, Hata K, Masui T, Okajima H, Haga H, Uemoto S, Hatano E. Increased expression of programmed cell death ligand 1 and galectin 9 in transplant recipients who achieved tolerance after immunosuppression withdrawal. Liver Transpl. 2021 Oct 16. doi: 10.1002/lt.26336. [Epub ahead of print] PubMed PMID: 34655506.	4.57	2
Hübscher SG, Feng S, Gouw AS, Haga H, Kang HJ, Kelly DA, Komuta M, Lesniak A, Popp BA, Verkade HJ, Yu E, Demetris AJ. Standardising the histological assessment of late post-transplant biopsies from paediatric liver allograft recipients. Liver Transpl. 2022 Apr 16. doi: 10.1002/lt.26482. [Epub ahead of print] PubMed PMID: 35429359.	5.799	1
Uebayashi EY, Okajima H, Uno S, Kadohisa M, Yamamoto M, Ogawa E, Okamoto T, Okumura S, Ogiso S, Ito T, Takeuchi Y, Hirata M, Yamada Y, Minamiguchi S, Hatano E, Haga H. Thirty-year follow-up of immunosuppression modulation: Impact on graft fibrosis and anti-HLA antibodies after pediatric liver transplantation. Liver Transpl. 2025 Aug 13. doi: 10.1097/LVT.0000000000000708. Online ahead of print. PubMed PMID: 40793997.	4.7

Reference

Impact Factor

Cites

Quartile

Koshiba T, Li Y, Takemura M, Wu Y, Sakaguchi S, Minato N, Wood KJ, Haga H, Ueda M, Uemoto S. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol. 2007 Feb;17(2):94-7. Epub 2006 Nov 10. PubMed PMID: 17306739.

1.624

145

Li Y, Zhao X, Cheng D, Haga H, Tsuruyama T, Wood K, Sakaguchi S, Tanaka K, Uemoto S, Koshiba T. The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients. Transplantation. 2008 Dec 27;86(12):1837-43. doi: 10.1097/TP.0b013e31818febc4. PubMed PMID: 19104431.

4.546

Yoshitomi M, Koshiba T, Haga H, Li Y, Zhao X, Cheng D, Miyagawa A, Sakashita H, Tsuruyama T, Ohe H, Ueda M, Okamoto S, Egawa H, Wood K, Sakaguchi S, Manabe T, Tanaka K, Uemoto S. Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation. Transplantation. 2009 Feb 27;87(4):606-14. doi: 10.1097/TP.0b013e318195a7cb. Erratum in: Transplantation. 2009 Apr 15;87(7):1104. PubMed PMID: 19307800.

4.546

Egawa H, Miyagawa-Hayashino A, Haga H, Teramukai S, Yoshizawa A, Ogawa K, Ogura Y, Okamoto S, Kaido T, Uemoto S. Non-inflammatory centrilobular sinusoidal fibrosis in pediatric liver transplant recipients under tacrolimus withdrawal. Hepatol Res. 2012 Sep;42(9):895-903. doi: 10.1111/j.1872-034X.2012.01003.x. Epub 2012 Apr 23. PubMed PMID: 22524409.

3.165

Aini W, Miyagawa-Hayashino A, Ozeki M, Adeeb S, Hirata M, Tamaki K, Uemoto S, Haga H. Accelerated telomere reduction and hepatocyte senescence in tolerated human liver allografts. Transpl Immunol. 2014 Aug;31(2):55-9. doi: 10.1016/j.trim.2014.06.008. Epub 2014 Jun 30. PubMed PMID: 24993398.

1.624

Aini W, Miyagawa-Hayashino A, Ozeki M, Tsuruyama T, Tamaki K, Uemoto S, Haga H. Frequent hepatocyte chimerism in long-term human liver allografts independent of graft outcome. Transpl Immunol. 2013 Mar;28(2-3):100-5. doi: 10.1016/j.trim.2012.12.002. Epub 2012 Dec 22. PubMed PMID: 23268137.

1.624

Hai Nam N, Taura K, Koyama Y, Nishio T, Yamamoto G, Uemoto Y, Kimura Y, Xuefeng L, Nakamura D, Yoshino K, Ogawa E, Okamoto T, Yoshizawa A, Seo S, Iwaisako K, Yoh T, Hata K, Masui T, Okajima H, Haga H, Uemoto S, Hatano E. Increased expression of programmed cell death ligand 1 and galectin 9 in transplant recipients who achieved tolerance after immunosuppression withdrawal. Liver Transpl. 2021 Oct 16. doi: 10.1002/lt.26336. [Epub ahead of print] PubMed PMID: 34655506.

4.57

Hübscher SG, Feng S, Gouw AS, Haga H, Kang HJ, Kelly DA, Komuta M, Lesniak A, Popp BA, Verkade HJ, Yu E, Demetris AJ. Standardising the histological assessment of late post-transplant biopsies from paediatric liver allograft recipients. Liver Transpl. 2022 Apr 16. doi: 10.1002/lt.26482. [Epub ahead of print] PubMed PMID: 35429359.

5.799

Uebayashi EY, Okajima H, Uno S, Kadohisa M, Yamamoto M, Ogawa E, Okamoto T, Okumura S, Ogiso S, Ito T, Takeuchi Y, Hirata M, Yamada Y, Minamiguchi S, Hatano E, Haga H. Thirty-year follow-up of immunosuppression modulation: Impact on graft fibrosis and anti-HLA antibodies after pediatric liver transplantation. Liver Transpl. 2025 Aug 13. doi: 10.1097/LVT.0000000000000708. Online ahead of print. PubMed PMID: 40793997.

4.7

Address

Biomedical Informatics & Bioinformatics Platform
Institute for Bio-health Research of Murcia (IMIB-Arrixaca)
Carretera Buenavista s/n, 30120
El Palmar, Murcia, Spain